Controlled release of liposomes from biodegradable dextran microspheres: A novel delivery concept

被引:0
作者
Stenekes, RJH
Loebis, AE
Fernandes, CM
Crommelin, DJA
Hennink, WE
机构
[1] Univ Utrecht, Inst Pharmaceut Sci, Dept Pharmaceut, NL-3508 TB Utrecht, Netherlands
[2] OctoPlus BV, NL-2300 AS Leiden, Netherlands
关键词
controlled release; liposomes; hydrogel; dextran; microspheres;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To design liposome-loaded microspheres, which release the liposomes in a time-controlled manner and in intact form. Methods. Liposomes were encapsulated in biodegradable dextran-based microspheres, which were prepared using an aqueous two phase system consisting of poly(ethylene glycol) and methacrylated dextran. The effects of liposome size and membrane fluidity, microsphere water content, degree of methacrylate substitution, and type of dextran derivative used, on encapsulation efficiency, release, and integrity of the liposomes were investigated. Results. Liposomes were entrapped in dextran-based microspheres quantitatively and with full preservation of their integrity. Liposomes with a low, as well as with a high membrane fluidity, were released from the microspheres in their intact form and with preservation of their size. Release kinetics depended only on the degradation rate of the microspheres. For rapidly degrading systems, pulsed release was observed and the time after which the pulse occurred (from 5 until 25 days) could be tailored by the gel characteristics such as initial water content, degree of methacrylate substitution, and type of hydrolytically sensitive spacer present in the cross-links. This delay time was not dependent on the size of the liposomes in the range studied (0.1-0.2 mu m). Microspheres which degraded more slowly showed, after a certain delay time, sustained release of the liposomes extended up to 100 days. Conclusions. A novel drug delivery concept based on the encapsulation of liposomes in biodegradable dextran-based microspheres was designed. The system released the liposomes in intact form in a controlled way after a prolonged period of time.
引用
收藏
页码:690 / 695
页数:6
相关论文
共 30 条
[1]  
ALLEN TM, 1984, LIPOSOME TECHNOLOGY, P178
[2]   INTERLEUKIN-2-CONTAINING LIPOSOMES - INTERACTION OF INTERLEUKIN-2 WITH LIPOSOMAL BILAYERS AND PRELIMINARY STUDIES ON APPLICATION IN CANCER VACCINES [J].
BERGERS, JJ ;
DENOTTER, W ;
DULLENS, HFJ ;
KERKVLIET, CTM ;
CROMMELIN, DJA .
PHARMACEUTICAL RESEARCH, 1993, 10 (12) :1715-1721
[3]   Synthesis, characterization of 2-(methacryloyloxy)ethyl-(di-) L-lactate and their application in dextran-based hydrogels [J].
Cadée, JA ;
De Kerf, M ;
De Groot, CJ ;
Den Otter, W ;
Hennink, WE .
POLYMER, 1999, 40 (24) :6877-6881
[4]  
CADEE JA, 2000, IN PRESS J BIOMED MA
[5]   THE PHARMACOKINETICS OF, AND HUMORAL RESPONSES TO, ANTIGEN DELIVERED BY MICROENCAPSULATED LIPOSOMES [J].
COHEN, S ;
BERNSTEIN, H ;
HEWES, C ;
CHOW, M ;
LANGER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10440-10444
[6]   STABILITY OF LIPOSOMES ON STORAGE - FREEZE-DRIED, FROZEN OR AS AN AQUEOUS DISPERSION [J].
CROMMELIN, DJA ;
VANBOMMEL, EMG .
PHARMACEUTICAL RESEARCH, 1984, (04) :159-163
[7]   CONTROLLED VACCINE RELEASE IN THE GUT-ASSOCIATED LYMPHOID-TISSUES .1. ORALLY-ADMINISTERED BIODEGRADABLE MICROSPHERES TARGET THE PEYERS PATCHES [J].
ELDRIDGE, JH ;
HAMMOND, CJ ;
MEULBROEK, JA ;
STAAS, JK ;
GILLEY, RM ;
TICE, TR .
JOURNAL OF CONTROLLED RELEASE, 1990, 11 (1-3) :205-214
[8]   Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres [J].
Franssen, O ;
Vandervennet, L ;
Roders, P ;
Hennink, WE .
JOURNAL OF CONTROLLED RELEASE, 1999, 60 (2-3) :211-221
[9]   Delayed release of a model protein from enzymatically-degrading dextran hydrogels [J].
Franssen, O ;
Vos, OP ;
Hennink, WE .
JOURNAL OF CONTROLLED RELEASE, 1997, 44 (2-3) :237-245
[10]   A novel preparation method for polymeric microparticles without the use of organic solvents [J].
Franssen, O ;
Hennink, WE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 168 (01) :1-7